Clinical outcomes of CDK4/6 inhibitors in patients with bone only metastatic breast cancer

被引：1
|
作者：
Mardani, Mahta
Noordeen, Suleyman
Clifton, Katherine
Ma, Cynthia
Luo, Jingqin
Xi, Jing
Bagegni, Nusayba
Ademuyiwa, Foluso
Suresh, Rama
Frith, Ashley
Davis, Andrew
Bose, Ron
Peterson, Lindsay
Thomas, Shana
Tao, Yu
Kobayashi, Takayuki
Xiang, Jingyu
Xu, Yalin
Su, Xinming
Weilbaecher, Katherine
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO5-05-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO5-05-05
引用
收藏
页数：3
相关论文
共 50 条
  • [11] Clinical effectiveness of CDK4/6 inhibitors in HER2-low metastatic breast cancer
    Zhang, Frank
    Mesias, Jesus Anampa
    CANCER RESEARCH, 2024, 84 (09)
  • [12] Accessibility of CDK4/6 inhibitors for breast cancer patients in the Netherlands
    Luyendijk, Marianne
    Blommestein, Hedwig
    Jager, Agnes
    Siesling, Sabine
    Uyl-de Groot, Carin
    CANCER RESEARCH, 2022, 82 (04)
  • [13] Update on CDK4/6 Inhibitors in Breast Cancer
    Tolaney, Sara M.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2024, 22 (06) : 298 - 300
  • [14] The Role of CDK4/6 Inhibitors in Breast Cancer
    Murphy, Conleth G.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (06)
  • [15] Breast Cancer CDK4/6 Inhibitors in Patients with metastatic HR+/HER2-Breast Cancer
    Schmale, Ine
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 (1-2)
  • [16] The Role of CDK4/6 Inhibitors in Breast Cancer
    Conleth G. Murphy
    Current Treatment Options in Oncology, 2019, 20
  • [17] CDK4/6 inhibitors in luminal breast cancer
    Gnant, Michael
    Steger, Guenther G.
    Bartsch, Rupert
    LANCET ONCOLOGY, 2015, 16 (01): : 2 - 3
  • [18] Safety and efficacy of concomitant RT and CDK4/6 inhibitors in metastatic breast cancer patients.
    Visani, L.
    Saieva, C.
    Desideri, I.
    Scotti, V.
    Dominici, L.
    Scoccimarro, E.
    Aquilano, M.
    Cerbai, C.
    Palmieri, V. E.
    Maragna, V.
    Becherini, C.
    Bernini, M.
    Sanchez, L.
    Orzalesi, L.
    Nori, J.
    Antonuzzo, L.
    Bianchi, S.
    Meattini, I.
    Livi, L.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S495 - S496
  • [19] Safety of CDK4/6 inhibitors and concomitant radiation therapy in patients affected by metastatic breast cancer
    Visani, L.
    Becherini, C.
    Scoccimarro, E.
    Valzano, M.
    Saieva, C.
    Ratosa, I.
    Ribnikar, D.
    Orazem, M.
    Marinko, T.
    Desideri, I.
    Scotti, V.
    Morandi, A.
    Lambertini, M.
    Meattini, I.
    Livi, L.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S643 - S643
  • [20] Safety of CDK4/6 Inhibitors Combined with Radiotherapy in Patients with Metastatic Breast Cancer: A Review of the Literature
    Franco, Rejane
    Cao, Jeffrey Q.
    Yassa, Michael
    Hijal, Tarek
    CURRENT ONCOLOGY, 2023, 30 (06) : 5485 - 5496
12345